Dr. Gloria Haskell earned her PhD in Neurobiology from UNC-Chapel Hill where she also worked as a research associate investigating the clinical implementation of whole exome sequencing in the hospital setting. She completed American Board of Medical Genetics and Genomics-accredited fellowship programs in both clinical cytogenetics and clinical molecular genetics at Duke University, where she gained broad expertise in clinical genetic testing for a wide range of heritable medical genetic conditions and acquired malignancies.
She holds certification in Cytogenetics, Molecular Genetics, and Molecular Oncology from the New York State Department of Health and holds a California director license. While at Labcorp she has led several process improvement projects, feasibility studies, and assay validations. She holds professional memberships in the Association of Molecular Pathology (2015 Young Investigator award winner), the Cancer Genomics Consortium (2018-2020 Breast cancer working group co-leader) the American College of Medical Genetics (2024 Annual Meeting Platform Presenter) and has published numerous articles as well as a book chapter in the areas of molecular and cytogenomic diagnostics. Dr. Haskell has served as a Paternity and Relationship testing director, a Clinical Laboratory Director, and currently serves as the CLIA Director for Labcorp’s DNA Identity, HLA, and Consumer Genetics laboratories.